198 results on '"Zhuang, Zhixiang"'
Search Results
2. Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study
3. Peripheral CD4+CD25hiCD127low regulatory T cells are increased in patients with gastrointestinal cancer
4. Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
5. Microspheres-mediated magnetic thermal ablation combined with immune checkpoint blockade therapy for liver cancer
6. Artificial sweetener and respiratory system cancer: A Mendelian randomization analysis
7. DDX24 promotes tumor progression by mediating hexokinase-1 induced glycolysis in gastric cancer
8. Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study
9. Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies
10. Research on Design Scheme of 500 kV Double Circuit Composite Cross Arm Tangent Tower
11. Research on the Relationship Between Structural Engineering Quantitie and Multi Ice Area of ± 500 kV DC Tansmission Line Engineering
12. A fine-tuned machine learning model to predict survivals of breast cancer patients based on gamma-delta T cell markers
13. Research on Key Technologies of 220 kV Single Circuit Composite Tower
14. GBP5 drives malignancy of glioblastoma via the Src/ERK1/2/MMP3 pathway
15. Comparison between ultrasound-guided TIVAD via the right innominate vein and the right internal jugular vein approach
16. TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway
17. Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
18. Clinical efficacy and biomarker analysis of pucotenlimab (HX008) in patients with previously treated advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A single-arm, multicenter, phase 2 study.
19. Gunagratinib, a highly selective irreversible FGFR inhibitor, in patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR pathway alterations: A phase IIa dose-expansion study.
20. Pain Incidence and Associated Risk Factors among Cancer Patients within 72 Hours after Surgery: A Large Retrospective Analysis
21. [Retracted] MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis
22. Central Nervous System Efficacy of Rezivertinib (BPI-7711) in Advanced NCLC Patients with EGFR T790m Mutation: A Pooled Analysis of Two Clinical Trials
23. Abstract CT542: Preliminary safety and efficacy results of KN046 in combination with KN026 in patients with locally advanced unresectable or metastatic HER2-positive solid cancer
24. Peripheral CD4+CD25hiCD127low regulatory T cells are increased in patients with gastrointestinal cancer.
25. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression
26. Safety, Efficacy, and Pharmacokinetics of Rezivertinib (BPI-7711) in Patients With Advanced NSCLC With EGFR T790M Mutation: A Phase 1 Dose-Escalation and Dose-Expansion Study
27. Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients
28. Synergistic Effect of 3-Bromopyruvate in Combination with Rapamycin Impacted Neuroblastoma Metabolism by Inhibiting Autophagy
29. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer
30. Inhibition of Musashi-1 enhances chemotherapeutic sensitivity in gastric cancer patient-derived xenografts
31. Regulation of NSCLC Cell Proliferation By MARCH7 Via the NF-κB and Wnt/β-Catenin Signaling Pathways
32. Antenatal dexamethasone retarded fetal long bones growth and development by down-regulating of insulin-like growth factor 1 signaling in fetal rats
33. Long non-coding RNA HAGLROS regulates the proliferation, migration, and apoptosis of esophageal cancer cells via the HAGLROS-miR-206-NOTCH3 axis
34. B7-H3 on breast cancer cell MCF7 inhibits IFN-γ release from tumour-infiltrating T cells
35. Downregulation of LINC00115 inhibits the proliferation and invasion of lung cancer cells in vitro and in vitro
36. TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway
37. Efficacy of HX008 in high microsatellite instability/mismatch repair–defificient (MSI-H/dMMR) solid tumors: Results from a multicenter phase II open-label study.
38. TYMSOS drives the proliferation, migration, and invasion of gastric cancer cells by regulating ZNF703 via sponging miR‐4739
39. Prognostic factors analysis of 138 patients with stage IV gastric cancer
40. Effect of the Weekly Administration of Liposome–Paclitaxel Combined with S-1 on Advanced Gastric Cancer
41. MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis
42. Analysis of Height-to-Width Ratio of Commercial Streets with Arcades Based on Sunshine Hours and Street Orientation
43. YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway
44. Perioperative and Postoperative Complications of Ultrasound-Guided Totally Implantable Venous Access Ports via the Brachiocephalic Vein in Patients with Cancer: A Prospective Study
45. Superparamagnetic iron oxide nanoparticles enhance glioma radiosensitivity via inducing cell cycle arrest and apoptosis
46. LncRNA NUTM2A‐AS1 positively modulates TET1 and HIF‐1A to enhance gastric cancer tumorigenesis and drug resistance by sponging miR‐376a
47. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial
48. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer
49. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer
50. Prognostic effects of the expression of inhibitor of DNA‑binding family members on patients with lung adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.